Studying Heart Ablation After Left Atrial Closure in High-Bleeding-Risk Atrial Fibrillation Patients

Part of paid clinical trials in Chicago, Illinois.

Sponsor
University of Chicago
Study ID
NCT07580937
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Data collection — OTHER
    Data collection on patient characteristics and comorbidities, baseline echocardiographic data, home medications including oral anticoagulation regimen, ablation data, left atrial appendage occlusion device data, and complication-related details from routine procedures and encounters

Study Details

The purpose of this multicenter study is to collect information from routine clinical practices for patients with left atrial appendage occlusion (LAAO) devices presenting for pulmonary vein isolation (PVI) or left atrial ablation. Assessment will include characterization of patient characteristics, procedural details, management of post-procedure anticoagulation, and clinical outcomes.

Key Dates

Start date
Mar 8, 2022
Status verified
May 2026
Primary completion
Dec 10, 2024
Completion
Mar 30, 2026

Study Design

Enrollment
198 participants (actual)

Arms

  • Arm: Individuals undergoing atrial ablation for routine care
    Individuals undergoing any type of atrial fibrillation ablation or left atrial arrhythmia ablation for routine care

Primary Outcome Measure

Patient characteristics [ Time Frame: Month 0, baseline ]

Locations (10)

FacilityCityStateZIPSite coordinators
Loyola UniversityChicagoIllinois60660-
Rush University Medical CenterChicagoIllinois60612-
University of ChicagoChicagoIllinois60637-
Northwestern UniversityEvanstonIllinois60208-
Beth Israel Deaconess Medical CenterBostonMassachusetts02215-
Brigham and Women's HospitalBostonMassachusetts02115-
University of MichiganAnn ArborMichigan48109-
Wake Forest University Health SciencesWinston-SalemNorth Carolina27157-
University of PennsylvaniaPhiladelphiaPennsylvania19104-
Medical University of South CarolinaCharlestonSouth Carolina29425-

Find similar trials in Chicago, IL

Related Studies